返回
WuXi Biologics (Cayman) Inc.（02269.HK）价格
02269.HK 股价走势图
WUXI BIO (02269.HK)
WuXi Biologics (Cayman) Inc.
HK$39.78
2.89%
$1.12
休市： Jan 16, 16:00:00 HKT
暂无数据Earnings FAQ
02269.HK 最近的每股收益与预期相比如何？
WuXi Biologics (Cayman) Inc. 02269.HK 上一季度的收入表现如何？
WuXi Biologics (Cayman) Inc. 的收入预期是多少？
WuXi Biologics (Cayman) Inc. 的盈利质量评分是多少？
WuXi Biologics (Cayman) Inc. 何时发布财报？
WuXi Biologics (Cayman) Inc. 的预期收益是多少？
WuXi Biologics (Cayman) Inc. 是否超出收益预期？
关键数据
前收盘价
$40.02
开盘价
$38.66
当日区间
$38.54 - $40.04
52周范围
$16.18 - $42.6
交易量
219.2M
平均成交量
30.8M
每股收益（TTM）
1.09
股息收益率
--
市值
$164.2B
什么是 WUXI BIO？
Wuxi Biologics (Cayman), Inc. is an investment holding company, which provides end-to-end solutions and services for biologics discovery, development, and manufacturing services and manufacturing of biologics products. The company is headquartered in Wuxi, Jiangsu and currently employs 12,552 full-time employees. The company went IPO on 2017-06-13. The firm mainly operates its business through two segments. The Biologics segment mainly engages in the provision of biologics discovery, development and manufacturing. The WuXi XDC (XDC) segment mainly engages in the provision of contract research, development and manufacturing organization (CRDMO) services for antibody-drug conjugate (ADCs) and various bioconjugates. The firm mainly conducts its business in the domestic and overseas markets.